1 Mouse ®broblasts (NIH3T3) transfected with the full-length coding region of the Mel 1a melatonin receptor stably expressed the receptor, coupled to a pertussis toxin-sensitive G-protein(s) and exhibiting high a nity and adequate pharmacological pro®le. 2 The receptor protein had the tendency of a strong coupling to the G-protein and therefore lowa nity state was induced by uncoupling the receptor from its G-protein in presence of high concentrations of NaCl (500 ± 700 mM) and/or GTPgS (100 mM). Thereafter, the a nity of a series of melatonin analogues was determined to both, high-and low-a nity receptor states, thus providing a basis for the prediction of their e cacy, according to the ternary complex model. 3 The cells were subsequently used to study the agonist-induced G-protein activation, determined by calculating the rate of GDP-GTP exchange measured in presence of 35 S-labelled GTPgS. The natural ligand melatonin induced a signi®cant increase in the GDP-GTP exchange rate, the presence of GDP and NaCl being necessary to observe this e ect. 4 The full agonists 2-phenylmelatonin, 2-bromomelatonin and 6-chloromelatonin equally induced an increase of the GDP-GTP exchange. 5-Hydroxy-N-acetyltryptamine activated the GTP-GDP exchange to a much lesser extent (53%) than melatonin, thus behaving as a partial agonist. As predicted by the model, the melatonin antagonist (N-[(2-phenyl-1H-indol-3-yl)ethyl]cyclobutanecarboxamide) was without e ect on basal G protein activation. Coincubation of this compound with melatonin induced a dosedependent rightward shift in the melatonin concentration-e ect curve, thus exhibiting the behaviour of a competitive and surmountable antagonist. 5 Using the equation proposed by Venter (1997) we were able to determine that there were no`spare' receptors in the system. Therefore, the approach proposed in the present work can be successfully used for the determination of`drug action' at the level of the human Mel 1a melatonin receptor and evaluation of the e cacy of new selective melatonin analogues.